Literature DB >> 21403972

The mass-action law based algorithms for quantitative econo-green bio-research.

Ting-Chao Chou1.   

Abstract

The relationship between dose and effect is not random, but rather governed by the unified theory based on the median-effect equation (MEE) of the mass-action law. Rearrangement of MEE yields the mathematical form of the Michaelis-Menten, Hill, Henderson-Hasselbalch and Scatchard equations of biochemistry and biophysics, and the median-effect plot allows linearization of all dose-effect curves regardless of potency and shape. The "median" is the universal common-link and reference-point for the 1st-order to higher-order dynamics, and from single-entities to multiple-entities and thus, it allows the all for one and one for all unity theory to "integrate" simple and complex systems. Its applications include the construction of a dose-effect curve with a theoretical minimum of only two data points if they are accurately determined; quantification of synergism or antagonism at all dose and effect levels; the low-dose risk assessment for carcinogens, toxic substances or radiation; and the determination of competitiveness and exclusivity for receptor binding. Since the MEE algorithm allows the reduced requirement of the number of data points for small size experimentation, and yields quantitative bioinformatics, it points to the deterministic, efficient, low-cost biomedical research and drug discovery, and ethical planning for clinical trials. It is concluded that the contemporary biomedical sciences would greatly benefit from the mass-action law based "Green Revolution".

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21403972     DOI: 10.1039/c0ib00130a

Source DB:  PubMed          Journal:  Integr Biol (Camb)        ISSN: 1757-9694            Impact factor:   2.192


  11 in total

1.  The mass-action law based algorithm for cost-effective approach for cancer drug discovery and development.

Authors:  Ting-Chao Chou
Journal:  Am J Cancer Res       Date:  2011-08-05       Impact factor: 6.166

Review 2.  Comparing the Safety and Efficacy of L-Glutamine, Voxelotor, and Crizanlizumab for Reducing the Frequency of Vaso-Occlusive Crisis in Sickle Cell Disease: A Systematic Review.

Authors:  Maurice H Dick; Arowa Abdelgadir; Vaishnavi Vijaya Kulkarni; Hamna Akram; Abanti Chatterjee; Sushil Pokhrel; Safeera Khan
Journal:  Cureus       Date:  2022-05-11

3.  Synergistic combination of microtubule targeting anticancer fludelone with cytoprotective panaxytriol derived from panax ginseng against MX-1 cells in vitro: experimental design and data analysis using the combination index method.

Authors:  Ning Zhang; Jia-Ning Fu; Ting-Chao Chou
Journal:  Am J Cancer Res       Date:  2015-12-15       Impact factor: 6.166

4.  Quantitative Characterization of the Toxicities of Cd-Ni and Cd-Cr Binary Mixtures Using Combination Index Method.

Authors:  Lingyun Mo; Minyi Zheng; Meng Qin; Xin Zhang; Jie Liu; Litang Qin; Honghu Zeng; Yanpeng Liang
Journal:  Biomed Res Int       Date:  2016-12-01       Impact factor: 3.411

5.  Combining DL-Methionine and Bacillus thuringiensis Subspecies israelensis: Prospects for a Mosquito Larvicide.

Authors:  Elise A Richardson; Nicole O Abruzzo; Caitlin E Taylor; Bruce R Stevens; James P Cuda; Emma N I Weeks
Journal:  Insects       Date:  2020-12-11       Impact factor: 2.769

6.  In Vitro Systematic Drug Testing Reveals Carboplatin, Paclitaxel, and Alpelisib as a Potential Novel Combination Treatment for Adult Granulosa Cell Tumors.

Authors:  Joline Roze; Elena Sendino Garví; Ellen Stelloo; Christina Stangl; Ferdinando Sereno; Karen Duran; Jolijn Groeneweg; Sterre Paijens; Hans Nijman; Hannah van Meurs; Luc van Lonkhuijzen; Jurgen Piek; Christianne Lok; Geertruida Jonges; Petronella Witteveen; René Verheijen; Gijs van Haaften; Ronald Zweemer; Glen Monroe
Journal:  Cancers (Basel)       Date:  2021-01-20       Impact factor: 6.639

7.  Evaluation of the Multimycotoxin-Degrading Efficiency of Rhodococcus erythropolis NI1 Strain with the Three-Step Zebrafish Microinjection Method.

Authors:  Edina Garai; Anita Risa; Emese Varga; Mátyás Cserháti; Balázs Kriszt; Béla Urbányi; Zsolt Csenki
Journal:  Int J Mol Sci       Date:  2021-01-13       Impact factor: 5.923

8.  Anti-Cholinesterase Combination Drug Therapy as a Potential Treatment for Alzheimer's Disease.

Authors:  Hafsa Amat-Ur-Rasool; Mehboob Ahmed; Shahida Hasnain; Wayne G Carter
Journal:  Brain Sci       Date:  2021-02-02

9.  Optimizing combinations of flavonoids deriving from astragali radix in activating the regulatory element of erythropoietin by a feedback system control scheme.

Authors:  Hui Yu; Wendy L Zhang; Xianting Ding; Ken Y Z Zheng; Chih-Ming Ho; Karl W K Tsim; Yi-Kuen Lee
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-30       Impact factor: 2.629

10.  Combination of TPF regimen and cinobufotalin inhibits proliferation and induces apoptosis in human hypopharyngeal and laryngeal squamous cell carcinoma cells.

Authors:  Xixi Shen; Yong Tao; Yifan Yang; Ru Wang; Jugao Fang; Meng Lian
Journal:  Onco Targets Ther       Date:  2018-12-31       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.